Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Evidence-Based Hair

J. Donovan

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

Yusuf Yazici

Behçet Syndrome Diagnosis: How and When Do Major/Minor Clinical Mani…

Haner Direskeneli

GI Manifestations of Rheumatologic Disorders in Women

Jefferson Health

C. Choudhary

EULAR® 2024 Insights: Manifestations and Predictors of Neurologic In…

EULAR® 2024 Insights

M. Lucas Rocha

Neuro-Ocular Diseases Case Overview: Which Uncommon Diseases Affect …

Cleveland Clinic Rheumatology

R. Hajj-Ali

Off-Label Use of Biologics: Apremilast and Dupilumab

[PRIVATE] 2022 AAD Annual Meeting Coverage

D. Rosmarin

Behcet's Disease: Approach to Diagnosis

Hospital for Special Surgery

J. Nowatzky

Behcet's Syndrome 2020 Update: What Is the Efficacy of TNF Antogonis…

Nebraska Rheumatology Society

Y. Yazici

EADV 2022: Microbiota and Biofilms in Hidradenitis Suppurativa

EADV 2022 Conference Coverage

A. Nassif

Challenges of Neurological Presentations in Rheumatic Diseases: Lab …

McMaster University Department of Medicine

E. Shosha

2020 Update on Behcet's Syndrome: What Are ISG Criteria of Condition…

Nebraska Rheumatology Society

Y. Yazici

When Meningitis Strikes Twice

RheumNow

A. Moyer

Potpourri: Rare Neuroimmunological Disorders to Keep in Mind

ZINCARE

P. Barreras

Cases of Caution in Inpatient Neuroimmunology: When the First Diagno…

Northwestern Medicine Neurology and Neurosurgery

E. Graham

GCA & Steroid Weaning

RheumNow

J. Cush

Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Evidence-Based Hair

J. Donovan

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

New and Emerging Treatments in Cutaneous Vasculitis

Cleveland Clinic Rheumatology

C. Langford